Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium...

Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule

Dodion, P., Rozencweig, M., Nicaise, C., Piccart, M., Cumps, E., Crespeigne, N., Kisner, D., Kenis, Y.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
European Journal of Cancer and Clinical Oncology
DOI:
10.1016/0277-5379(82)90220-6
Date:
June, 1982
File:
PDF, 382 KB
english, 1982
Conversion to is in progress
Conversion to is failed